AAAAAA

   
Results: 1-8 |
Results: 8
ENTEROCUTANEOUS FISTULA IN CANCER-PATIENTS - ETIOLOGY, MANAGEMENT, OUTCOME, AND IMPACT ON FURTHER TREATMENT
Authors: CHAMBERLAIN RS KAUFMAN HL DANFORTH DN
Citation: Rs. Chamberlain et al., ENTEROCUTANEOUS FISTULA IN CANCER-PATIENTS - ETIOLOGY, MANAGEMENT, OUTCOME, AND IMPACT ON FURTHER TREATMENT, The American surgeon, 64(12), 1998, pp. 1204-1211
ROUTE OF IMMUNIZATION AND THE THERAPEUTIC IMPACT OF RECOMBINANT ANTICANCER VACCINES
Authors: IRVINE KR CHAMBERLAIN RS SHULMAN EP ROSENBERG SA RESTIFO NP
Citation: Kr. Irvine et al., ROUTE OF IMMUNIZATION AND THE THERAPEUTIC IMPACT OF RECOMBINANT ANTICANCER VACCINES, Journal of the National Cancer Institute, 89(5), 1997, pp. 390-392
ENHANCING EFFICACY OF RECOMBINANT ANTICANCER VACCINES WITH PRIME BOOST REGIMENS THAT USE 2 DIFFERENT VECTORS/
Authors: IRVINE KR CHAMBERLAIN RS SHULMAN EP SURMAN DR ROSENBERG SA RESTIFO NP
Citation: Kr. Irvine et al., ENHANCING EFFICACY OF RECOMBINANT ANTICANCER VACCINES WITH PRIME BOOST REGIMENS THAT USE 2 DIFFERENT VECTORS/, Journal of the National Cancer Institute, 89(21), 1997, pp. 1595-1601
HIGHLY ATTENUATED MODIFIED VACCINIA VIRUS ANKARA (MVA) AS AN EFFECTIVE RECOMBINANT VECTOR - A MURINE TUMOR-MODEL
Authors: CARROLL MW OVERWIJK WW CHAMBERLAIN RS ROSENBERG SA MOSS B RESTIFO NP
Citation: Mw. Carroll et al., HIGHLY ATTENUATED MODIFIED VACCINIA VIRUS ANKARA (MVA) AS AN EFFECTIVE RECOMBINANT VECTOR - A MURINE TUMOR-MODEL, Vaccine, 15(4), 1997, pp. 387-394
THE ROUTE OF ADMINISTRATION OF RECOMBINANT VACCINIA VIRUS (RVV) VACCINES EFFECTS THE ACTIVE TREATMENT OF CANCER
Authors: IRVINE KR CHAMBERLAIN RS BRONTE V ROSENBERG SA RESTIFO NP
Citation: Kr. Irvine et al., THE ROUTE OF ADMINISTRATION OF RECOMBINANT VACCINIA VIRUS (RVV) VACCINES EFFECTS THE ACTIVE TREATMENT OF CANCER, The FASEB journal, 10(6), 1996, pp. 2711-2711
IL-12 IS AN EFFECTIVE ADJUVANT TO RECOMBINANT VACCINIA VIRUS-BASED TUMOR VACCINES - ENHANCEMENT BY SIMULTANEOUS B7-1 EXPRESSION
Authors: RAO JB CHAMBERLAIN RS BRONTE V CARROLL MW IRVINE KR MOSS B ROSENBERG SA RESTIFO NP
Citation: Jb. Rao et al., IL-12 IS AN EFFECTIVE ADJUVANT TO RECOMBINANT VACCINIA VIRUS-BASED TUMOR VACCINES - ENHANCEMENT BY SIMULTANEOUS B7-1 EXPRESSION, The Journal of immunology, 156(9), 1996, pp. 3357-3365
COSTIMULATION ENHANCES THE ACTIVE IMMUNOTHERAPY EFFECT OF RECOMBINANTANTICANCER VACCINES
Authors: CHAMBERLAIN RS CARROLL MW BRONTE V HWU P WARREN S YANG JC NISHIMURA M MOSS B ROSENBERG SA RESTIFO NP
Citation: Rs. Chamberlain et al., COSTIMULATION ENHANCES THE ACTIVE IMMUNOTHERAPY EFFECT OF RECOMBINANTANTICANCER VACCINES, Cancer research, 56(12), 1996, pp. 2832-2836
COMPLETE SURGICAL RESECTION COMBINED WITH AGGRESSIVE ADJUVANT CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION PROLONGS SURVIVAL IN CHILDREN WITH ADVANCED NEUROBLASTOMA
Authors: CHAMBERLAIN RS QUINONES R DINNDORF P MOVASSAGHI N GOODSTEIN M NEWMAN K
Citation: Rs. Chamberlain et al., COMPLETE SURGICAL RESECTION COMBINED WITH AGGRESSIVE ADJUVANT CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION PROLONGS SURVIVAL IN CHILDREN WITH ADVANCED NEUROBLASTOMA, Annals of surgical oncology, 2(2), 1995, pp. 93-100
Risultati: 1-8 |